1. Home
  2. Stocks
  3. Monopharma Share Price

Mono Pharmacare Share Price

Trading Small Cap

₹35.80 +1.7 (4.99%)

05 Nov, 2024 21:06

SIP TrendupStart SIP in MONOPHARMA

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹35
  • High
  • ₹36
  • 52 Week Low
  • ₹33
  • 52 Week High
  • ₹75
  • Open Price₹35
  • Previous Close₹34
  • Volume6,000

Investment Returns

  • Over 1 Month -2.85%
  • Over 3 Month -13.32%
  • Over 6 Month -22.17%
  • Over 1 Year -26.19%
SIP Lightning

Smart Investing Starts Here Start SIP with Mono Pharmacare for Steady Growth!

Mono Pharmacare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • PEG Ratio
  • Market Cap Cr
  • 63
  • P/B Ratio
  • 2.2
  • Average True Range
  • 1.43
  • EPS
  • 1.4
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.73
  • RSI
  • 49.69
  • MFI
  • 29.25

Mono Pharmacare Financial

IndicatorMar 24Mar 23
Revenue From Operations [Gross]70.7245.40
Revenue From Operations [Net]70.7245.40
Total Operating Revenues70.7245.40
Total Revenue72.4245.66
Total Expenses69.5644.09
Profit/Loss Before Tax2.861.57
Profit/Loss For The Period2.441.23
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-10.32-6.95
Net Cash Used In Investing Activity-1.66-2.82
Net Cash Used in Finance Activity12.009.75
Net Inc/Dec In Cash And Equivalent0.02-0.02
Cash And Equivalent End Of Year0.250.23
IndicatorMar 24Mar 23
Total Share Capital17.6712.37
Total Non-Current Liabilities4.383.43
Total Current Liabilities12.9212.23
Total Capital And Liabilities45.4029.07
Total Non-Current Assets3.762.22
Total Current Assets41.6426.84
Total Assets45.4029.07
Indicator20242023
EBIT Margin (%)5.755.50
Return On Capital Employed (%)12.5214.83
Return On Equity (%)8.689.20
Long Term Debt To Equity (%)15.4225.63
Book Value/Share (INR)15.9110.83
IndicatorMar 24Mar 23
Revenue From Operations [Gross]122.3458.48
Revenue From Operations [Net]122.3458.48
Total Operating Revenues122.3458.48
Total Revenue122.4458.61
Total Expenses119.2156.94
Profit/Loss Before Tax3.231.68
Profit/Loss For The Period2.461.23
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-12.16-27.75
Net Cash Used In Investing Activity0.56-1.44
Net Cash Used in Finance Activity9.8029.61
Net Inc/Dec In Cash And Equivalent-1.800.42
Cash And Equivalent End Of Year0.360.42
IndicatorMar 24Mar 23
Total Share Capital17.6912.37
Total Non-Current Liabilities17.1718.01
Total Current Liabilities35.8231.20
Total Capital And Liabilities81.1162.60
Total Non-Current Assets0.951.48
Total Current Assets80.1661.12
Total Assets81.1162.60
Indicator20242023
EBIT Margin (%)5.155.12
Return On Capital Employed (%)13.929.55
Return On Equity (%)8.689.20
Long Term Debt To Equity (%)60.92134.57
Book Value/Share (INR)15.9010.83

Mono Pharmacare Technicals

EMA & SMA

Current Price
₹35.80
+ 1.7 (4.99%)
pointer
  • stock-down_img
  • Bullish Moving Average 6
  • stock-up_img
  • Bearish Moving Average 10
  • 20 Day
  • ₹35.55
  • 50 Day
  • ₹37.08
  • 100 Day
  • ₹39.51
  • 200 Day
  • ₹43.34

Resistance and Support

35.57 Pivot Speed
  • R3 36.73
  • R2 36.27
  • R1 36.03
  • S1 35.33
  • S2 34.87
  • S3 34.63

Is Mono Pharmacare Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Mono Pharmacare Ltd has an operating revenue of Rs. 246.07 Cr. on a trailing 12-month basis. An annual revenue growth of 109% is outstanding, Pre-tax margin of 3% needs improvement, ROE of 8% is fair but needs improvement. The company has a debt to equity of 61%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 5 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 45 indicates it belongs to a fair industry group of Medical-Whlsle Drg/Suppl and a Master Score of E is the worst. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Mono Pharmacare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-08-06 Others To take note of resignation of Mrs. Pooja Seth as Company Secretary and Compliance Officer of the Company and other business matters.
2024-04-29 Others To consider other business matters

Mono Pharmacare F&O

Mono Pharmacare Shareholding Pattern

56.72%
36.69%
6.59%
  • NSE Symbol
  • MONOPHARMA
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Panilam Lakhatariya
  • ISIN
  • INE0OIP01012

Mono Pharmacare FAQs

Mono Pharmacare share price is ₹35 As on 05 November, 2024 | 20:52

The Market Cap of Mono Pharmacare is ₹63.3 Cr As on 05 November, 2024 | 20:52

The P/E ratio of Mono Pharmacare is As on 05 November, 2024 | 20:52

The PB ratio of Mono Pharmacare is 2.2 As on 05 November, 2024 | 20:52

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.